Titan Pharmaceuticals Announces Reverse Stock Split and Ratio
SOUTH SAN FRANCISCO, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) — Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today…
Pharmaceuticals, Biotechnology and Life Sciences
SOUTH SAN FRANCISCO, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) — Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today…
COPENHAGEN, Denmark, Dec. 28, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that Jan Mikkelsen, President &…
SEATTLE, Dec. 27, 2023 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to…
New record date expected to be January 11, 2024 Company intends to seek judicial dissolution if the liquidation and dissolution…
MONMOUTH JUNCTION, N.J., Dec. 27, 2023 (GLOBE NEWSWIRE) — Elucida Oncology, a clinical-stage biotechnology company pioneering the next frontier in…
BOCA RATON, Fla., Dec. 27, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (“First Wave BioPharma” or the “Company”) (NASDAQ:…
IRVINE, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets NYMXF) is pleased to provide this end-of-the…
CHESTERBROOK, Pa., Dec. 27, 2023 (GLOBE NEWSWIRE) — Trevena Inc. (“Trevena” or the “Company”) (Nasdaq: TRVN), a biopharmaceutical company focused…
This Study performs unique rapid on-site measurements of interleukin-6 (IL-6) and positions Company to move forward with multiple initiatives. ACTON,…
– Primary Endpoint of Safety and Efficacy Met with Clinical Activity and Increased Survival Observed – – 70.3 Weeks Median…